MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs

Nature

Volumn 454, Issue 7205, 2008, Pages 780-783

  Umbach, Jennifer Lin ^a   Kramer, Martha F ^b   Jurak, Igor ^b   Karnowski, Heather W ^a   Coen, Donald M ^b   Cullen, Bryan R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; TRANSCRIPTION FACTOR; VIRUS RNA;

GENE EXPRESSION; PROTEIN; RNA; VIRUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; LATENT VIRUS INFECTION; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS LATENCY; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; MALE; MICE; MICRORNAS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; RNA, VIRAL; UBIQUITIN-PROTEIN LIGASES; VIRUS LATENCY;

ANIMALIA; HUMAN HERPESVIRUS 1;

EID: 49649119633     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature07103     Document Type: Article

References (37)

1. Bloom, D. C. HSV LAT and neuronal survival. Int. Rev. Immunol. 23, 187-198 (2004).
2. Stevens, J. G., Wagner, E. K., Devi-Rao, G. B., Cook, M. L. & Feldman, L. T. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235, 1056-1059 (1987).
3. Everett, R. D. ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 22, 761-770 (2000).
4. Preston, C. M. Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK. J. Virol. 29, 275-284 (1979).
5. Chen, S. H., Kramer, M. F., Schaffer, P. A. & Coen, D. M. A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 71, 5878-5884 (1997).
6. Garber, D. A., Schaffer, P. A. & Knipe, D. M. A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J. Virol. 71, 5885-5893 (1997).
7. Thompson, R. L. & Sawtell, N. M. Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J. Virol. 75, 6660-6675 (2001).
8. Thompson, R. L. & Sawtell, N. M. The herpes simplex virus type 1 latencyassociated transcript gene regulates the establishment of latency. J. Virol. 71, 5432-5440 (1997).
9. Sawtell, N. M. & Thompson, R. L. Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J. Virol. 66, 2157-2169 (1992).
10. Farrell,M. J.,Dobson, A. T.&Feldman, L. T. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl Acad. Sci. USA 88, 790-794 (1991).
11. Kang, W. et al. Characterization of a spliced exon product of herpes simplex type-1 latency-associated transcript in productively infected cells. Virology 356, 106-114 (2006).
12. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
13. Hafner, M. et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 44, 3-12 (2008).
14. Perng, G. C. et al. A novel herpes simplex virus type 1 transcript (AL-RNA) antisense to the 59 end of the latency-associated transcript produces a protein in infected rabbits. J. Virol. 76, 8003-8010 (2002).
15. Cui, C. et al. Prediction and identification of herpes simplex virus 1-encoded microRNAs. J. Virol. 80, 5499-5508 (2006).
16. Dölken, L. et al. Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J. Virol. 81, 13771-13782 (2007).
17. Feldman, L. T. et al. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc. Natl Acad. Sci. USA 99, 978-983 (2002).
18. Sawtell, N. M. Comprehensive quantification of herpes simplex virus latency at the single-cell level. J. Virol. 71, 5423-5431 (1997).
19. Gupta, A., Gartner, J. J., Sethupathy, P., Hatzigeorgiou, A. G. & Fraser, N. W. Antiapoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442, 82-85 (2006).
20. Cai, W. et al. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J. Virol. 67, 7501-7512 (1993).
21. Halford, W. P., Kemp, C. D., Isler, J. A., Davido, D. J. & Schaffer, P. A. ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells. J. Virol. 75, 6143-6153 (2001).
22. Chen, S. H. et al. Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus. J. Virol. 76, 4764-4772 (2002).
23. Thompson, R. L., Shieh, M. T. & Sawtell, N. M. Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo. J. Virol. 77, 12319-12330 (2003).
24. Pfeffer, S. et al. Identification of virus-encoded microRNAs. Science 304, 734-736 (2004).
25. Yeh, L. & Schaffer, P. A. A novel class of transcripts expressed with late kinetics in the absence of ICP4 spans the junction between the long and short segments of the herpes simplex virus type 1 genome. J. Virol. 67, 7373-7382 (1993).
26. 134.5 gene and may account for the attenuation of the mutant virus. J. Virol. 71, 7750-7757 (1997).
27. 134.5 transcripts and latency-associated transcripts. J. Virol. 72, 4250-4264 (1998).
28. Murphy, E., Vanicek, J., Robins, H., Shenk, T. & Levine, A. J. Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc. Natl Acad. Sci. USA 105, 5453-5458 (2008).
29. Coen, D. M., Fleming, H. E. Jr, Leslie, L. K. & Retondo, M. J. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus. J. Virol. 53, 477-488 (1985).
30. Goldin, A. L., Sandri-Goldin, R. M., Levine, M. & Glorioso, J. C. Cloning of herpes simplex virus type 1 sequences representing the whole genome. J. Virol. 38, 50-58 (1981).
31. Sekulovich, R. E., Leary, K. & Sandri-Goldin, R. M. The herpes simplex virus type 1 α protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0. J. Virol. 62, 4510-4522 (1988).
32. Brummelkamp, T. R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).
33. Wiegand, H. L., Doehle, B. P., Bogerd, H. P. & Cullen, B. R. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 23, 2451-2458 (2004).
34. Cai, X. et al. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc. Natl Acad. Sci. USA 102, 5570-5575 (2005).
35. Alvira, M. R., Goins, W. F., Cohen, J. B. & Glorioso, J. C. Genetic studies exposing the splicing events involved in herpes simplex virus type 1 latency-associated transcript production during lytic and latent infection. J. Virol. 73, 3866-3876 (1999).
36. Leib, D. A. et al. Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J. Virol. 63, 759-768 (1989).
37. Chen, C. et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33, e179 (2005).